Migraine is one of the most common neurological disorders, and for decades it has been debated whether migraine with aura (MwA) and migraine without aura (MwoA) are merely different manifestations of the same disease or whether they are two distinct entities. A recent narrative review in the Journal of Headache and Pain summarizes the available data on epidemiology, genetics, clinical characteristics, neuroimaging and treatment response. The result: there is increasing evidence that the two subtypes differ not only in terms of symptoms, but also in their biological basis. For neurologists, this raises the question of whether understanding these differences should also have diagnostic and therapeutic consequences in the future.
You May Also Like
- Sensation of pain
Special features for people with multiple disabilities
- Atopic dermatitis
Clinic, therapy and prevention in early childhood
- Prevention of skin cancer
UV protection and skin cancer screening – Update 2025
- Pain and autism
Hurdles to pain treatment for autistic patients
- Electrolyte disturbance
Hyponatremia in the outpatient setting
- Chronic musculoskeletal pain
How can the use of analgesics be optimized in multimodal therapy?
- Findings from the TRACK-FA study
Neuroimaging biomarkers in Friedreich’s ataxia
- Chronic inducible urticaria